Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02050854
What this trial is testing

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

Who this might be right for
Bipolar 1 DisorderSchizophreniaMental Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 47
Post-approval studies (Phase 4)Study completedNCT04903353
What this trial is testing

Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole

Who this might be right for
Weight GainAutism Spectrum DisorderMedication Side Effect
Vanderbilt University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00183235
What this trial is testing

Aripiprazole Effects on Alcohol Reactivity and Consumption

Who this might be right for
Alcohol Dependence
Medical University of South Carolina 30
Post-approval studies (Phase 4)Study completedNCT00545675
What this trial is testing

Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness

Who this might be right for
Bipolar Disorder
Korea Otsuka Pharmaceutical Co., Ltd. 146
Not applicableUnknownNCT00541502
What this trial is testing

Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder

Who this might be right for
Psychotic Disorders
Genovate Biotechnology Co., Ltd.,
Post-approval studies (Phase 4)Ended earlyNCT00508157
What this trial is testing

Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome

Who this might be right for
Metabolic SyndromeSchizophrenia
Bristol-Myers Squibb 125
Post-approval studies (Phase 4)Not Yet RecruitingNCT06590298
What this trial is testing

Evaluating the Effects of Adjunctive Aripiprazole on Weight and Metabolic Outcomes in Females

Who this might be right for
PsychosisMetabolic SyndromeWeight Gain
Universiti Putra Malaysia 600
Large-scale testing (Phase 3)Study completedNCT01567527
What this trial is testing

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 731
Early research (Phase 1)Study completedNCT05532254
What this trial is testing

Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting Condition

Who this might be right for
Healthy Subjects
Future University in Egypt 31
Post-approval studies (Phase 4)Ended earlyNCT01813656
What this trial is testing

Aripiprazole in the Treatment of Methamphetamine Dependence

Who this might be right for
Methamphetamine Dependence
Wei Hao 10
Post-approval studies (Phase 4)Study completedNCT00299702
What this trial is testing

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 355
Large-scale testing (Phase 3)Study completedNCT00606229
What this trial is testing

Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 41
Large-scale testing (Phase 3)Study completedNCT00705783
What this trial is testing

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 843
Post-approval studies (Phase 4)WithdrawnNCT01193166
What this trial is testing

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

Who this might be right for
Schizophrenia
Ortho-McNeil Janssen Scientific Affairs, LLC
Post-approval studies (Phase 4)Study completedNCT00300846
What this trial is testing

Adjunctive Treatment of Aripiprazole in Schizophrenic Patients

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 200
Large-scale testing (Phase 3)Study completedNCT01421342
What this trial is testing

VA Augmentation and Switching Treatments for Improving Depression Outcomes

Who this might be right for
Major Depressive Disorder
VA Office of Research and Development 1,522
Early research (Phase 1)Study completedNCT01646827
What this trial is testing

An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Large-scale testing (Phase 3)Study completedNCT00876343
What this trial is testing

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Co., Ltd. 586
Large-scale testing (Phase 3)Study completedNCT00095524
What this trial is testing

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

Who this might be right for
Body Weight ChangeSchizophreniaSchizoaffective Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 300
Large-scale testing (Phase 3)Study completedNCT00606320
What this trial is testing

A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 59
Next Page